Document ID: chunk:federal_register_of_legislation:F2024C01228:reg:114
Version: federal_register_of_legislation:F2024C01228
Segment Type: reg
Provision Reference: reg 114
Character Range: 70799–73765

114   Vaccine                                                                                                                                                                                                                                                                                Bexsero            Injection (0.5mL)                                                                 50 µg Neisseria meningitidis serogroup B Neisseria heparin binding antigen fusion protein                                                                                                                                                                                                                                                                      As described in subsection 7(13)
      Multicomponent meningococcal group B (4CMenB)

      Circumstances                                                                                                                                                                                                                                                                                                                                                                               50 µg Neisseria meningitidis serogroup B Neisseria adhesion A protein
      Vaccine may be provided:
       (a) in the circumstances set out in subsection 7(13); or
       (b) to a person who is undergoing treatment, or will commence treatment, with Empavali (pegcetacoplan) for the treatment of adults with paroxysmal nocturnal haemoglobinuria who have an inadequate clinical response or are intolerant to treatment with eculizumab or ravulizumab.                                                                                                       50 µg Neisseria meningitidis serogroup B factor H binding protein fusion protein

                                                                                                                                                                                                                                                                                                                                                                                                  25 µg outer membrane vesicles from Neisseria meningitidis serogroup B strain NZ98/254 (measured as amount of total protein containing the PorA P1.4)

Part 2 Viral vaccines
Item   Vaccine and the circumstances in which vaccine may be provided                                                                                                                                                                                                                                                                         Brand                            Formulation                                                 Active ingredient and strength                                                                               Number and timing of doses